Morgan Stanley’s Longeveron LGVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$478 Hold
680
﹤0.01% 7673
2026
Q1
$707 Sell
680
-9
-1% -$6 ﹤0.01% 7534
2025
Q4
$349 Buy
689
+1
+0.1% +$1 ﹤0.01% 7568
2025
Q3
$516 Hold
688
﹤0.01% 7490
2025
Q2
$894 Sell
688
-637
-48% -$885 ﹤0.01% 7343
2025
Q1
$2.05K Sell
1,325
-388
-23% -$634 ﹤0.01% 7170
2024
Q4
$2.96K Sell
1,713
-148
-8% -$291 ﹤0.01% 7124
2024
Q3
$3.61K Buy
1,861
+452
+32% +$1.16K ﹤0.01% 6998
2024
Q2
$2.27K Buy
1,409
+1,400
+15,556% +$2.45K ﹤0.01% 7041
2024
Q1
$29 Sell
9
-61
-87% -$409 ﹤0.01% 7644
2023
Q4
$952 Hold
70
﹤0.01% 7140
2023
Q3
$1.64K Hold
70
﹤0.01% 7161
2023
Q2
$2.37K Hold
70
﹤0.01% 7160
2023
Q1
$1.87K Sell
70
-392
-85% -$13.6K ﹤0.01% 7247
2022
Q4
$14.9K Sell
462
-406
-47% -$14.4K ﹤0.01% 6800
2022
Q3
$32K Buy
868
+738
+568% +$40.8K ﹤0.01% 6596
2022
Q2
$8K Sell
130
-5
-4% -$431 ﹤0.01% 7275
2022
Q1
$19K Buy
135
+40
+42% +$3K ﹤0.01% 7170
2021
Q4
$11K Buy
95
+75
+375% +$7.97K ﹤0.01% 7443
2021
Q3
$1K Buy
+20
New +$987 ﹤0.01% 7786

Other funds holding LGVN

Morgan Stanley's LGVN Position: Q2 2026 in Review

Morgan Stanley held its Longeveron (LGVN) position steady in Q2 2026 at 680 shares worth $478. The position accounts for ﹤0.01% of the portfolio, ranked #7673.

Morgan Stanley first reported a position in LGVN in Q3 2021 and has held it in 20 quarters since. The position peaked at $32K in Q3 2022. 39 funds tracked by Wall St. Rank hold LGVN as of Q2 2026.

  • Morgan Stanley held 680 shares of Longeveron worth $478 as of Q2 2026.
  • Morgan Stanley left its Longeveron share count unchanged in Q2 2026.
  • Longeveron made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #7673 holding.
  • Morgan Stanley first reported a position in Longeveron in Q3 2021 and has held it in 20 quarters since.
  • Morgan Stanley's Longeveron position peaked at $32K in Q3 2022.
  • 39 funds tracked by Wall St. Rank held Longeveron as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.